Clinical trial

A Phase Ⅰ b Clinical Study of ART101 Injection

NCT07614308

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2025-10-27

PhasePHASE1

Study timeline

Study start (actual)2025-10-27Date precision: day

Registry last updated2026-05-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertension (HTN)unresolved

Interventions

ART101 injectionDRUG

Sponsors & collaborators

Arnatar Therapeutics, Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07614308 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.